Capecitabine (X) improves quality of life (QoL) in patients (pts) with metastatic breast cancer (MBC).

被引：0
|
作者：
Segalla, J
Oliveira, C
Cabral, S
Lago, S
Ribeiro, R
Perdicaris, M
Abdo, E
Garicochea, B
Moore, F
Fabiani, C
机构：
[1] Fdn Amaral Carvalho, Jau Sao Paulo, Brazil
[2] Inst Brasileiro Controle Cancer, Sao Paulo, Brazil
[3] PUC, Hosp Sao Lucas, Porto Alegre, RS, Brazil
[4] Ctr Quimioterapia Antiblastica & Imunoterapia, Belo Horizonte, MG, Brazil
[5] Inst Canc Ceara, Fortaleza, Ceara, Brazil
[6] Beneficencia Portuguesa Santos, Santos, Brazil
[7] Hosp Perola Byngton, Sao Paulo, Brazil
[8] Fdn Benjamin Guimaraes, Belo Horizonte, MG, Brazil
[9] CEPON, Florianopolis, SC, Brazil
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [21] Improvements in quality of life (QoL) associated with capecitabine (X) treatment for metastatic breast cancer (MBC) in Brazil: Updated results from a large cohort of 1683 patients (pts), including analysis as a function of ECOG PS.
    Tosello, C.
    Segolla, J. G. M.
    Ribeiro, R.
    Tessoro, S.
    Cabral, S.
    Frank, F.
    Perdicaris, M.
    de Paula, U.
    Moura, G.
    Rego, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S237 - S237
  • [22] Quality of life (QoL) improvements in 1,464 patients (pts) with metastatic breast cancer (MBC) receiving capecitabine (X) in Brazil: Updated results from a large pt cohort, including analysis as a function of pts' ECOG PS.
    Oliveira, C.
    Ribeiro, R.
    Segalla, J. G.
    Tessaro, S.
    Cabral, S.
    Franke, F. A.
    De Paula, U.
    Moura, G. L.
    Perdicaris, M. R.
    Garicochea, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 492S - 492S
  • [23] Improvements in quality of life (QoL) in 1210 patients (pts) with metastatic colorectal cancer (MCRC) receiving capecitabine (X) in Brazil:: Impact on oncology nursing
    Goncalves, D.
    Almeida, L.
    Xara, M.
    Nunes, S.
    Ferro, R.
    Oliveira, A.
    Vasquez, M.
    Aguiar, O.
    Martins, F.
    Cini, D.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2006, 10 (03) : 229 - 230
  • [24] Treatment with capecitabine (X) improves quality of life (QOL) in patients (PTS) with metastatic colorectal cancer (MCRC): Updated findings from a large cohort of 1437 PTS in Brazil with analysis as a function of ECOG PS
    Beato, Carlos
    VanEyll, Brigitte
    Federico, Mirian
    Skare, Nills
    Franke, Fabio
    Perdicaris, Martha
    Tosello, Celia
    Gampel, Otavio
    Cabral, Sebastiao
    Ribeiro, Ronaldo
    ANNALS OF ONCOLOGY, 2006, 17 : 118 - 119
  • [25] Pharmacogenetic study in patients (pts) with metastatic breast (MBC) and colorectal cancer (MCRC) treated with capecitabine (C)
    Alba, E.
    Ribelles, N.
    Sanchez, A.
    Lopez Siles, J.
    Sanchez, M. J.
    Gonzalez, E.
    Carabantes, F.
    Sanchez Rovira, P.
    Marquez, A.
    Sevilla, I.
    EJC SUPPLEMENTS, 2005, 3 (02): : 66 - 66
  • [26] Capecitabine (X) plus vinorelbine (N) as second-line therapy in Chinese patients (pts) with metastatic breast cancer (MBC).
    Xu, B
    Tian, L
    Wu, Q
    Zhou, M
    Wang, H
    Tong, Z
    Li, H
    Li, L
    Hu, G
    Shi, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 73S - 73S
  • [27] Capecitabine (X) monotherapy in patients (pts) with pretreated metastatic breast cancer (MBC): Is response correlated to cerbB-2 expression?
    Sezgin, VC
    Sanli, UA
    Karabulut, B
    Uslu, R
    Muezzinoglu, GG
    Ozdemir, N
    Goker, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 66S - 66S
  • [28] Capecitabine (X) as single agent in elderly patients (p) with metastatic breast cancer (MBC).
    Zamora, P
    de Mon, MA
    Calvo, L
    Jara, C
    Virizuela, JA
    Yubero, A
    Chacón, JI
    Mira, J
    Barón, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 88S - 88S
  • [29] Efficacy and tolerability of capecitabine (X) monotherapy in metastatic breast cancer (MBC)
    Vasev, Nikola
    ANNALS OF ONCOLOGY, 2006, 17 : 75 - 75
  • [30] Minimization of treatment toxicity/side effects and their impact on quality of life (QoL) in patients (pts) with ER+/HER2metastatic breast cancer (mBC)
    Sammons, Sarah
    Meisel, Jane
    Shanahan, Kelly
    Pluard, Timothy
    Chino, Fumiko
    Trapani, Dario
    Carroll, Dominic
    Kozlowski, Monica
    Attias, Elizabeth
    Kuderer, Nicole
    CANCER RESEARCH, 2024, 84 (09)
12345